Evolving CLL treatments: creating choices and igniting discussions
Deborah Henderson et al.
Targeted therapy of AML
Overcoming the issues with clinical trial recruitment
Exciting new developments in multiple myeloma
Daniel Auclair et al.
Why MRD is a hot topic in CLL and how it should be used